Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$COMPASS Pathways (CMPS.US)$ NEWS Compass Pathways announces...

NEWS
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
6938 Views
Comment
Sign in to post a comment